These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 19263611)

  • 1. [Initial treatment for ovarian cancer].
    Suzuki M; Fujiwara H; Takei Y
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):224-9. PubMed ID: 19263611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adjuvant chemotherapy in primary radically operated ovarian cancer].
    Illiger HJ; del Valle F; Mühlenstedt D
    Onkologie; 1985 Oct; 8(5):316, 321-3. PubMed ID: 3906479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials of treatment of ovarian cancer.
    Klaassen DJ; Boyes DA; Gerulath A; Levitt M; Pearson JG; Dodds D; Miller AB
    Can Med Assoc J; 1975 Oct; 113(8):717. PubMed ID: 803183
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current topic of intraperitoneal infusions for treatment of ovarian cancer].
    Fujiwara K
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):224-227. PubMed ID: 18372511
    [No Abstract]   [Full Text] [Related]  

  • 5. Promising new developments in the systemic treatment of ovarian cancer.
    Reed E
    J Assoc Acad Minor Phys; 1994; 5(1):16-21. PubMed ID: 7513218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does secondary surgical cytoreduction improve survival in women with advanced ovarian cancer?
    Munkarah A
    Nat Clin Pract Oncol; 2005 Apr; 2(4):188-9. PubMed ID: 16264930
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advanced ovarian cancer: a need for redefining therapeutic objectives and strategy].
    Bugat R; Guastalla JP; Misset JL
    Bull Cancer; 2005 Nov; 92(11):1003-6. PubMed ID: 16316835
    [No Abstract]   [Full Text] [Related]  

  • 8. Aggressive surgery and ovarian cancer.
    Chi DS; Barakat RR
    J Clin Oncol; 2006 May; 24(15):2395-6; author reply 2396-7. PubMed ID: 16710043
    [No Abstract]   [Full Text] [Related]  

  • 9. Importance of early diagnosis in managing ovarian cancer.
    Dunleavey R
    Nurs Times; 2006 Oct 10-16; 102(41):28-9. PubMed ID: 17059048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial ovarian cancer: Does the time interval between primary surgery and postoperative chemotherapy have any prognostic importance?
    Larsen E; Blaakaer J
    Acta Obstet Gynecol Scand; 2009; 88(4):373-7. PubMed ID: 19253061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Second-line treatment using novel chemotherapeutic and biologic agents].
    Sugiyama T
    Gan To Kagaku Ryoho; 2009 May; 36(5):730-5. PubMed ID: 19461172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer: is dose intensity dead?
    Ozols RF
    J Clin Oncol; 2007 Sep; 25(27):4157-8. PubMed ID: 17698802
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraperitoneal therapy for ovarian cancer: a treatment ready for prime time.
    Armstrong DK; Brady MF
    J Clin Oncol; 2006 Oct; 24(28):4531-3. PubMed ID: 17008690
    [No Abstract]   [Full Text] [Related]  

  • 14. Ovarian cancer: current management.
    Tyler H; Kardinal CG
    Mo Med; 1981 Jan; 78(1):13-6. PubMed ID: 7219403
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of cancer of the ovary in advanced stages (III and IV)].
    Escudero M; Díaz-Rubio E; Vidart JA; Martín M; Herraiz MA; Hernández A
    Rev Clin Esp; 1990 Feb; 186(3):134-40. PubMed ID: 2192410
    [No Abstract]   [Full Text] [Related]  

  • 16. [A dynamic cytologic study during the chemotherapy of cancer of the ovaries].
    Iakimova TP; Iakovtsova II; Samsonova LA; Skripnik LD; Pavlova TD
    Lab Delo; 1990; (7):42-4. PubMed ID: 1699068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatments of epithelial ovarian cancer by histologic subtype].
    Sugiyama T; Kumagai S; Hatayama S
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):187-92. PubMed ID: 19223734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer.
    Gabra H; Redman C; Byrom J
    Clin Evid; 2003 Dec; (10):2170-83. PubMed ID: 15555197
    [No Abstract]   [Full Text] [Related]  

  • 19. New, expanded, and modified use of approved antineoplastic agents in ovarian cancer.
    Markman M
    Oncologist; 2007 Feb; 12(2):186-90. PubMed ID: 17296814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Potentialities of a cytomorphologic method in the evaluation of the efficacy of the treatment of cancer of the ovaries].
    Petrova S; Ali-zade VA
    Lab Delo; 1988; (10):31-5. PubMed ID: 2462084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.